跳至主要内容
临床试验/CTRI/2022/08/044984
CTRI/2022/08/044984招募中2 期

Efficacy of Durva(Cynodon dactylon Linn.Pers) As COMPLEXION PROMOTER W.S.R TO VARNYA PRASADAN-A CLINICAL STUDY

Parul Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Vounteers having normal or dull skin
  • Irrespective of sex

排除标准

  • volunteers age below 18 years and more than 40 years.
  • Volunteers having any skin disease like eczema,psoriasis.leukoderma,skin burn
  • any allergic skin conditions
  • Systemic disease Major illness will be excluded

研究者

发起方
Parul Institute of Ayurveda

相似试验

已完成
不适用
A clinical trial of Durva (Cynodon dactylon L. Pers.) Swaras Siddha Taila Abhyanga in Kacchu - A skin disease in Ayurveda.
CTRI/2020/01/023072Sane Guruji Arogya Kendra30
尚未招募
2 期
Efficacy and Safety of Dictyophora indusiata Fisch, Psilocybe cubensis (Earle) Sing. and Sesame oil compare with 0.1% Triamcinolone lotion in treating Psoriasis Patients: Open label , Randomized controlled trial.Psoriasis&#44a chronic skin cause by multifactorial factors such as immune activation&#44genetic and environment result in increased epidermal proliferation and inflammation. A wide range of treatments arExperimental&#44Open label &#44randomized control trial&#44Efficacy and Safety &#44treating&#44Psoriasis Patients&#44Herbal Recipe
TCTR20180125004n/a30
已完成
3 期
MERMAID-1This is a Phase III, randomized, parallel-arm, placebo controlled, double blind, multicenter study assessing the efficacy and safety of durvalumab versus placebo following SoC chemotherapy in patients with completely resected stage II-III NSCLC who are MRD+ post surgery
JPRN-jRCT2080225282AstraZeneca KK31
尚未招募
2 期
To study the effect of duralabhadi kashaya ghanvati and levofloxacin in urinary tract infectio
CTRI/2023/10/058212Parul Institute of ayurved
进行中(未招募)
1 期
Study to see the changes in body weight and body composition of a darunavir/cobicistat based treatment in HIV-infected people who have gained weight during a dolutegravir-based treatment.
EUCTR2019-004620-38-ESFundació Lluita contra la SIDA60
Durva gel for brighter complexio | 临床试验